Aarti Drugs expands anti-diabetic capacity

24 Oct 2019 Evaluate

Aarti Drugs has recently expanded its anti-diabetic capacity and currently scaling up its production quantities for the same. Further, brown field CAPEX would be done in the current financial year to expand few capacities in anti-inflammatory therapeutic category.

Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.

Aarti Drugs Share Price

360.00 5.00 (1.41%)
07-Apr-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.10
Dr. Reddys Lab 1200.95
Cipla 1206.40
Zydus Lifesciences 872.40
Lupin 2300.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×